Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.

about

Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis.Contrast-Induced Nephropathy: Update on the Use of Crystalloids and Pharmacological Measures.

P2860

Q49876490-25F7E932-CE70-4231-9203-DC62010F01EF Q55243370-C6017E10-BC94-40AF-BA78-580EE00C548A

P2860

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.

Item

http://www.wikidata.org/entity/Q38623589

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Oral N-acetylcysteine for prop ...... angioplasty: A meta-analysis.

@en

type

Item

label

Oral N-acetylcysteine for prop ...... angioplasty: A meta-analysis.

@en

prefLabel

Oral N-acetylcysteine for prop ...... angioplasty: A meta-analysis.

@en

P1476

Oral N-acetylcysteine for prop ...... angioplasty: A meta-analysis.

@en

P2093

En-Ze Jin

http://www.w3.org/2001/XMLSchema#string

Jing-Xiu Li

http://www.w3.org/2001/XMLSchema#string

Long-Hao Yu

http://www.w3.org/2001/XMLSchema#string

Nan-Nan Liu

http://www.w3.org/2001/XMLSchema#string

Xin Li

http://www.w3.org/2001/XMLSchema#string

Xue-Qi Li

http://www.w3.org/2001/XMLSchema#string

Yang Li

http://www.w3.org/2001/XMLSchema#string

Yu-Mei Dong

http://www.w3.org/2001/XMLSchema#string

P2860

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation

Arsenic trioxide induces the apoptosis in vascular smooth muscle cells via increasing intracellular calcium and ROS formation.

Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Guidelines on myocardial revascularization.

2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Associa

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.

Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).

Hospital-acquired renal insufficiency.

Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials

P304

1568-1576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4678

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28810622

http://www.w3.org/2001/XMLSchema#string

P932

5525578

http://www.w3.org/2001/XMLSchema#string

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.

about

P2860

P2860

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932